Identification of Escherichia coli β-glucuronidase inhibitors from Polygonum cuspidatum Siebold & Zucc

Gut bacterial beta-glucuronidase (GUS) can reactivate xenobiotics that exert enterohepatic circulation -triggered gastrointestinal tract toxicity. GUS inhibitors can alleviate drug-induced enteropathy and improve treatment outcomes. We evaluated the inhibitory effect of Polygonum cuspidatum Siebold & Zucc. and its major constituents against Escherichia coli GUS (EcGUS), and characterized the inhibitory mechanism of each of the components. Trans-resveratrol 4'-O-beta-D-glucopyranoside (HZ-1) and (-)-epicatechin gallate (HZ-2) isolated from P. cuspidatum were identified as the key components and potent inhibitors. These two components displayed strong to moderate inhibitory effects on EcGUS, with Ki values of 9.95 and 1.95 mu M, respectively. Results from molecular docking indicated that HZ-1 and HZ-2 could interact with the key residues Asp163, Ser360, Ile 363, Glu413, Glu504, and Lys 568 of EcGUS via hydrogen bonding. Our findings demonstrate the inhibitory effect of P. cuspidatum and its two components on EcGUS, which supported the further evaluation and development of P. cuspidatum and its two active components as novel candidates for alleviating drug-induced damage in the mammalian gut.

Automated summary

In this study, we evaluated the inhibitory effect of Polygonum cuspidatum and its major constituents against Escherichia coli GUS and characterized the inhibitory mechanism of each component. Trans-resveratrol 4'-O-beta-D-glucopyranoside and (-)-epicatechin gallate were identified as the key components and potent inhibitors. Our findings demonstrate the inhibitory effect of Polygonum cuspidatum and its two active components on Escherichia coli GUS, supporting their potential as novel candidates for alleviating drug-induced damage in the mammalian gut.